122 related articles for article (PubMed ID: 2158387)
21. D-CPP-ene (SDZ EAA 494), a potent and competitive N-methyl-D-aspartate (NMDA) antagonist: effect on spontaneous activity and NMDA-induced depolarizations in the rat neocortical slice preparation, compared with other CPP derivatives and MK-801.
Lowe DA; Neijt HC; Aebischer B
Neurosci Lett; 1990 Jun; 113(3):315-21. PubMed ID: 2166255
[TBL] [Abstract][Full Text] [Related]
22. Glutamate receptors of the N-methyl-D-aspartate subtype in the myenteric plexus of the guinea pig ileum.
Shannon HE; Sawyer BD
J Pharmacol Exp Ther; 1989 Nov; 251(2):518-23. PubMed ID: 2572691
[TBL] [Abstract][Full Text] [Related]
23. Effects of some excitatory amino acid antagonists on imipenem-induced seizures in DBA/2 mice.
De Sarro G; Ammendola D; Nava F; De Sarro A
Brain Res; 1995 Feb; 671(1):131-40. PubMed ID: 7728525
[TBL] [Abstract][Full Text] [Related]
24. Effects of the NMDA receptor/channel antagonists CPP and MK801 on hippocampal field potentials and long-term potentiation in anesthetized rats.
Abraham WC; Mason SE
Brain Res; 1988 Oct; 462(1):40-6. PubMed ID: 2846123
[TBL] [Abstract][Full Text] [Related]
25. Selective inhibition of synaptic versus non-synaptic epileptogenesis by NMDA antagonists in the in vitro hippocampus.
Ashton D; Willems R; De Prins E; Wauquier A
Epilepsy Res; 1988; 2(3):219-22. PubMed ID: 2848699
[TBL] [Abstract][Full Text] [Related]
26. Excitatory amino acid neurotoxicity at the N-methyl-D-aspartate receptor in cultured neurons: pharmacological characterization.
Lysko PG; Cox JA; Vigano MA; Henneberry RC
Brain Res; 1989 Oct; 499(2):258-66. PubMed ID: 2572298
[TBL] [Abstract][Full Text] [Related]
27. Effect of NMDA antagonists on the activity of glutaminase and aspartate aminotransferase in the developing rat cerebellum.
Moran J; Alavez S; Rivera-Gaxiola M; Valencia A; Hurtado S
Int J Dev Neurosci; 1999 Feb; 17(1):57-65. PubMed ID: 10219961
[TBL] [Abstract][Full Text] [Related]
28. Binding of [3H]3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid to rat brain membranes: a selective, high-affinity ligand for N-methyl-D-aspartate receptors.
Murphy DE; Schneider J; Boehm C; Lehmann J; Williams M
J Pharmacol Exp Ther; 1987 Mar; 240(3):778-84. PubMed ID: 3031274
[TBL] [Abstract][Full Text] [Related]
29. L-homocysteate stimulates [3H]MK-801 binding to the phencyclidine recognition site and is thus an agonist for the N-methyl-D-aspartate-operated cation channel.
Schwarz S; Zhou GZ; Katki AG; Rodbard D
Neuroscience; 1990; 37(1):193-200. PubMed ID: 1700841
[TBL] [Abstract][Full Text] [Related]
30. The pharmacological selectivity of three NMDA antagonists.
Childs AM; Evans RH; Watkins JC
Eur J Pharmacol; 1988 Jan; 145(1):81-6. PubMed ID: 2894999
[TBL] [Abstract][Full Text] [Related]
31. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II. Evidence for N-methyl-D-aspartate receptor antagonist properties.
Carter C; Benavides J; Legendre P; Vincent JD; Noel F; Thuret F; Lloyd KG; Arbilla S; Zivkovic B; MacKenzie ET
J Pharmacol Exp Ther; 1988 Dec; 247(3):1222-32. PubMed ID: 2849669
[TBL] [Abstract][Full Text] [Related]
32. N-methyl-D-aspartate promotes the survival of cerebellar granule cells: pharmacological characterization.
Balázs R; Hack N; Jørgensen OS; Cotman CW
Neurosci Lett; 1989 Jul; 101(3):241-6. PubMed ID: 2549463
[TBL] [Abstract][Full Text] [Related]
33. The effect of glutamate receptor blockade on anoxic depolarization and cortical spreading depression.
Lauritzen M; Hansen AJ
J Cereb Blood Flow Metab; 1992 Mar; 12(2):223-9. PubMed ID: 1312539
[TBL] [Abstract][Full Text] [Related]
34. Structure and activity of hydrogenated derivatives of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (MK-801).
Lyle TA; Magill CA; Britcher SF; Denny GH; Thompson WJ; Murphy JS; Knight AR; Kemp JA; Marshall GR; Middlemiss DN
J Med Chem; 1990 Mar; 33(3):1047-52. PubMed ID: 2155319
[TBL] [Abstract][Full Text] [Related]
35. Different modes of action of 3-amino-1-hydroxy-2-pyrrolidone (HA-966) and 7-chlorokynurenic acid in the modulation of N-methyl-D-aspartate-sensitive glutamate receptors.
Danysz W; Fadda E; Wroblewski JT; Costa E
Mol Pharmacol; 1989 Dec; 36(6):912-6. PubMed ID: 2574820
[TBL] [Abstract][Full Text] [Related]
36. The effect of NMDA antagonists in the radial arm maze task with an interposed delay.
Butelman ER
Pharmacol Biochem Behav; 1990 Mar; 35(3):533-6. PubMed ID: 2160086
[TBL] [Abstract][Full Text] [Related]
37. NMDA and non-NMDA receptors mediate visual responses of neurons in the cat's lateral geniculate nucleus.
Kwon YH; Esguerra M; Sur M
J Neurophysiol; 1991 Aug; 66(2):414-28. PubMed ID: 1685510
[TBL] [Abstract][Full Text] [Related]
38. Competitive and noncompetitive N-methyl-D-aspartate antagonists modify hypoxia-induced membrane potential changes and protect rat hippocampal slices from functional failure: a quantitative comparison.
Grigg JJ; Anderson EG
J Pharmacol Exp Ther; 1990 Apr; 253(1):130-5. PubMed ID: 1970359
[TBL] [Abstract][Full Text] [Related]
39. Effects of 5-HT1A receptor agonists and NMDA receptor antagonists in the social interaction test and the elevated plus maze.
Dunn RW; Corbett R; Fielding S
Eur J Pharmacol; 1989 Oct; 169(1):1-10. PubMed ID: 2574684
[TBL] [Abstract][Full Text] [Related]
40. Protection by NMDA receptor antagonists against seizures induced by intracerebral administration of 4-aminopyridine.
Morales-Villagrán A; Ureña-Guerrero ME; Tapia R
Eur J Pharmacol; 1996 Jun; 305(1-3):87-93. PubMed ID: 8813536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
